financetom
Business
financetom
/
Business
/
Cintas to Implement 4-For-1 Stock Split
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cintas to Implement 4-For-1 Stock Split
May 2, 2024 3:23 PM

05:58 PM EDT, 05/02/2024 (MT Newswires) -- Cintas ( CTAS ) board approved a stock split at a ratio of four common shares for one share, to be distributed after market close on Sept. 11 to shareholders of record on Sept. 4, the company said Thursday.

The company expects its shares to begin trading on a post-split basis on Sept. 12.

The split will increase the company's number of outstanding shares to roughly 404 million from about 101 million, it said.

Price: 663.99, Change: +1.70, Percent Change: +0.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Helius Medical Files FDA Application to Expand Device Indication to Include Post-Stroke Gait Correction
Helius Medical Files FDA Application to Expand Device Indication to Include Post-Stroke Gait Correction
Sep 25, 2025
08:27 AM EDT, 09/25/2025 (MT Newswires) -- Helius Medical Technologies ( HSDT ) said Thursday it filed a 510(k) submission to the US Food and Drug Administration for its portable neuromodulation stimulator device, seeking a label expansion to cover an indication for gait and balance deficit in patients with chronic stroke symptoms. The company said the submission was filed under...
Canada's Real Estate Market Primed for Buyers But First-Timers Are Moving at Their Own Pace, Says Royal LePage
Canada's Real Estate Market Primed for Buyers But First-Timers Are Moving at Their Own Pace, Says Royal LePage
Sep 25, 2025
08:25 AM EDT, 09/25/2025 (MT Newswires) -- 13% of Canadian adults are working towards their first residential property purchase within the next two years, with a majority of them planning to buy in the next 12 to 24 months, according to a Royal LePage survey released on Thursday. More than half (53%) of first-time buyers plan to put at least...
MediWound Says Australia Granted Marketing Authorization For NexoBrid
MediWound Says Australia Granted Marketing Authorization For NexoBrid
Sep 25, 2025
08:27 AM EDT, 09/25/2025 (MT Newswires) -- MediWound ( MDWD ) said Thursday that Australia's Therapeutic Goods Administration has granted a marketing authorization to the company's NexoBrid. The company said its exclusive partner in Australia expects a commercial launch of NexoBrid in Q4. MediWound ( MDWD ) further said that its manufacturing expansion is on track for completion by the...
BRIEF-Respira Therapeutics Says Enters Into Agreement Granting Gossamer Option To Acquire Co From Samsara Biocapital
BRIEF-Respira Therapeutics Says Enters Into Agreement Granting Gossamer Option To Acquire Co From Samsara Biocapital
Sep 25, 2025
Sept 25 (Reuters) - Gossamer Bio ( GOSS ): * RESPIRA THERAPEUTICS ENTERS INTO AGREEMENT WITH GOSSAMER BIO (GOSSAMER) GRANTING GOSSAMER OPTION TO ACQUIRE RESPIRA FROM SAMSARA BIOCAPITAL Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved